Supplements slow disease progression during late stage of “dry” age-related macular degeneration
On Jul. 16, 2024, researchers at the National Institutes of Health (NIH) reported they have found that taking…
Artificial Intelligence (AI) made retinal imaging 100 times faster, compared to manual method
On Apr. 10, 2024, researchers at the National Institutes of Health (NIH) applied artificial intelligence (AI) to a…
Extremely rare gene variants point to a potential cause of age-related macular degeneration
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
Biotechnology | Disease | Medicine | NIH | Ophthalmogy | Therapeutics
NIH study confirmed benefit of supplements for slowing age-related macular degeneration
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
NIH researchers discovered tooth-enamel protein in eyes with dry AMD
On Mar. 17, 2020, researchers at the National Eye Institute (NEI) reported finding a protein that normally deposits…
NIH launched first US clinical trial of patient-derived stem cell therapy to replace dying cells in retina
On Dec. 16, 2019, researchers at the National Eye Institute launched a clinical trial to test the safety…
Scientists at Sanford Burnham Prebys have identified the long-sought structure of an essential blood protein: Vitronectin
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
UNMC macular degeneration, regenerative medicine research bolstered by $1.3 million gift
On Dec. 18, 2014, the University of Nebraska Medical Center announced it had received a $1.3 million gift…
Lucentis approved for treatment of diabetic macular edema
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research opened
On Oct. 29, 2010, The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research…
Genentech drug Lucentisﾙ (ranibizumab injection) was approved
On Jun. 30, 2006, Genentech drug Lucentisﾙ (ranibizumab injection) was approved by the FDA for the treatment of…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Ophthalmogy
OHSU researcher uncovered macular degeneration gene
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
University of Iowa established the Center for Macular Degeneration
In 1997, the University of Iowa established the Center for Macular Degeneration. Its mission was to identify the…
VEGF molecule was discovered
In 1993, Massachusetts Eye and Ear researchers discovered the Vascular endothelial growth factor (VEGF) molecule, implicated in diabetic…